Costa Rica cancer plan to involve private sector
This article was originally published in Clinica
Costa Rica is a step closer to launching a national cancer plan, with the aim of stemming an expected significant rise in incidence of the disease. Health ministry representatives have held a meeting of experts from the national cancer institute (CCC), medical colleges, the national social security fund, the Pan-American Health Organization and "private sector players" to discuss a draft of the programme.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.